Miv Therapeutics, Inc. (IVT) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts IVT Hot Sheet
Join SI Premium – FREE
Miv Therapeutics, Inc. (NYSE: IVT) reported Q2 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $82.83 million versus the consensus estimate of $81.12 million.
For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Miv Therapeutics, Inc. (IVT) Tops Q3 EPS by 21c; Offers Guidance
- Baker Hughes Company (BKR) Tops Q3 EPS by 10c
- National Research Corporation (NRC) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
